Thomas A Hamilton

Title: Innovations by Thomas A. Hamilton

Introduction

Thomas A. Hamilton is an accomplished inventor based in Cleveland, OH. He has made significant contributions to the field of medical research, particularly in the treatment of IL-17 mediated diseases. His innovative approach has the potential to impact various inflammatory and autoimmune conditions.

Latest Patents

Hamilton holds a patent for a method of treating IL-17 mediated diseases by blocking SEFIR-SEFIR interactions. This patent describes a method of administering a therapeutically effective amount of a cell-permeable decoy peptide that competitively inhibits the binding of the SEFIR domain of IL-17R to the SEFIR domain of Act1. The research highlights the importance of the αC helix region of the SEFIR domain in the association of IL-17R and Act1. To enhance cell permeation, the decoy peptide is preferably conjugated to a protein transduction domain. Examples of IL-17 mediated diseases include various human and animal inflammatory and autoimmune diseases, such as asthma. Hamilton has 1 patent to his name.

Career Highlights

Hamilton is affiliated with The Cleveland Clinic Foundation, where he continues to advance his research and innovations. His work is pivotal in developing new therapeutic strategies for challenging medical conditions.

Collaborations

He collaborates with notable colleagues, including Xiaoxia Li and Jarod Zepp, to further enhance the impact of his research.

Conclusion

Thomas A. Hamilton's contributions to the field of medical research through his innovative patent demonstrate his commitment to improving treatment options for IL-17 mediated diseases. His work at The Cleveland Clinic Foundation continues to pave the way for advancements in healthcare.